This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Enabling Biomanufacturing Technologies
Biomanufacturing technologies encompass the necessary infrastructure and facilities for fermentation processes.
Over the span of 2019 to 2022, investments in alternative protein have surged from $1 billion to $5 billion, with projections indicating a potential market size exceeding $200 billion by 2040. Given these robust market prospects and the rapid growth in investments, the realisation of this potential hinges upon the commitment of hundreds of billions of dollars into novel fermentation facilities to cater to escalating demand.
The primary hurdle faced by precision fermentation and cultivated meat enterprises pertains to the upscaling of their technological operations. To achieve cost parity with animal-derived products, these companies must effectively expand and enhance both their procedural methodologies and operational efficiencies. This imperative step is fundamental for bio-manufactured goods to serve as a practical remedy for concerns surrounding animal welfare, supply chain integrity, and ecological impacts.
Consequently, Agronomics not only invests in precision fermentation and cell culture techniques but also directs its investments towards companies actively developing the requisite infrastructure and technology to effectively address the burgeoning market demand.